AdvaMed Innovation Agenda Aligns With Capitol Hill Objectives
This article was originally published in The Gray Sheet
A review of AdvaMed’s “Innovation Agenda” for the coming year and the recent 21st Century Cures proposal in Congress suggests a supportive environment for the trade group's priorities.
You may also be interested in...
Following House passage of a combined House/Senate 21st Century Cures package Nov. 30, the Senate will take up the bill on Dec. 5 or 6, said Senate HELP Committee Chair Lamar Alexander, R-Tenn., who shepherded a similar package of medical innovation bills through the committee earlier this year. While some Democrats remain vocal in opposing the bill based on worries that it will water-down FDA safety protections and funding concerns, the House vote showed lopsided support, and the Senate is expected to pass it and the president to sign.
Legislation that would require Medicare administrative contractors to shine a light on their processes for making local coverage determinations for medical services and technologies has been introduced in the US House.
Centralized institutional review board approvals for device trials, and removal of HIPAA privacy provisions that block registry data-sharing are among the ideas that are likely to make it into a draft bill planned for release in January as the next step in the House’s 21st Century Cures initiative.